Search
forResearch 10 of 1000+
- Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata
- Topical Janus kinase inhibitors: A review of applications in dermatology
- Oral and Topical Janus Kinase Inhibitors in Patients With Cutaneous T‐Cell Lymphoma: A Real‐World Single‐Center Experience
- Treatment of alopecia universalis with topical Janus kinase inhibitors – a double blind, placebo, and active controlled pilot study
- Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients
- Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib: A 32-week open-label extension study with optional narrow-band ultraviolet B
- Janus Kinase inhibitors in dermatology: a review
- Janus kinase inhibitors for alopecia areata: A narrative review
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- The role of Janus kinase inhibitors in the treatment of alopecia areata: A systematic review
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →